SG Americas Securities LLC lifted its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 146.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 13,792 shares of the technology company’s stock after buying an additional 8,198 shares during the period. SG Americas Securities LLC’s holdings in Veeva Systems were worth $2,900,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA lifted its stake in shares of Veeva Systems by 64.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,545,451 shares of the technology company’s stock worth $744,084,000 after purchasing an additional 1,392,256 shares during the period. State Street Corp lifted its position in Veeva Systems by 1.5% during the third quarter. State Street Corp now owns 3,293,141 shares of the technology company’s stock worth $691,132,000 after buying an additional 47,872 shares during the period. FMR LLC lifted its position in Veeva Systems by 25.7% during the third quarter. FMR LLC now owns 2,981,244 shares of the technology company’s stock worth $625,674,000 after buying an additional 610,021 shares during the period. Geode Capital Management LLC grew its holdings in Veeva Systems by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,765,236 shares of the technology company’s stock valued at $579,630,000 after buying an additional 149,807 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of Veeva Systems by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,558,592 shares of the technology company’s stock valued at $536,972,000 after acquiring an additional 1,081,501 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.
Insider Buying and Selling at Veeva Systems
In other news, SVP Jonathan Faddis sold 1,694 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total value of $390,128.20. Following the sale, the senior vice president now owns 8,061 shares in the company, valued at approximately $1,856,448.30. This represents a 17.37 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Thomas D. Schwenger sold 1,126 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the transaction, the insider now directly owns 27,013 shares in the company, valued at $6,483,390.13. The trade was a 4.00 % decrease in their position. The disclosure for this sale can be found here. 10.50% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Report on VEEV
Veeva Systems Trading Up 0.2 %
Veeva Systems stock opened at $223.37 on Friday. The stock has a 50 day moving average of $221.63 and a 200-day moving average of $210.89. The stock has a market cap of $36.26 billion, a P/E ratio of 55.15, a price-to-earnings-growth ratio of 2.01 and a beta of 0.84. Veeva Systems Inc. has a 52 week low of $170.25 and a 52 week high of $258.93.
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- There Are Different Types of Stock To Invest In
- Bloom Energy: Powering the Future With Decentralized Energy
- 3 Warren Buffett Stocks to Buy Now
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.